Opioid Misuse & Addiction
Inpatient versus Outpatient Treatment Outcomes for People with Opioid Use Disorder (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
This study will use a multi-state linked administrative database to compare opioid-related outcomes among Medicaid recipients admitted for treatment of opioid use disorder in outpatient and inpatient (or residential) facilities. Patient and organizational factors predicting higher retention in outpatient treatment for OUD will also be examined. These data will be used to generate hypotheses on how to improve retention in treatment.
Dan Hartung, PharmD, MPH
Associate Professor
Primary Care Opioid Use Disorders Treatment Trial Economic Analysis Study (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
This study will include analyses of VA databases to examine patient and organizational characteristics associated with buprenorphine termination during outpatient treatment for opioid use disorder. These analyses are critical for generating data and forming further hypotheses on how to implement targeted approaches to improve retention in treatment.
Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO
Professor of Medicine and Psychiatry
University of Utah Health
Developing a Prescription Opioid Registry across Diverse Health Systems (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
The goal of the proposed study is to expand the prescription opioid registry developed in study CTN 0061, across diverse health systems with harmonized EHR data, and leverage it to answer several key ‘next step’ research questions in response to the opioid crisis. We propose to adapt and expand the registry to 8 other health systems across the nation, initially within the Health System Node (HSN) to maximize efficiency in the short study timeframe, but with potential to be expanded to other nodes in the future.
Effects of Semaglutide and Tirzepatide on Incidence and Outcomes of Stimulant Use Disorders and Opioid Use Disorder in Real-world Populations: Target Trial Emulation Using Patient Electronic Health Records (GLP-SUD) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠